Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Noble Romans (NROM) EBIT (2016 - 2025)

Noble Romans has reported EBIT over the past 15 years, most recently at $819065.0 for Q3 2025.

  • Quarterly results put EBIT at $819065.0 for Q3 2025, up 96.6% from a year ago — trailing twelve months through Sep 2025 was $2.3 million (up 9.54% YoY), and the annual figure for FY2024 was $1.5 million, down 57.12%.
  • EBIT for Q3 2025 was $819065.0 at Noble Romans, down from $913999.0 in the prior quarter.
  • Over the last five years, EBIT for NROM hit a ceiling of $1.5 million in Q1 2023 and a floor of -$395.0 in Q4 2022.
  • Median EBIT over the past 5 years was $432203.0 (2024), compared with a mean of $516921.6.
  • Biggest five-year swings in EBIT: plummeted 272.64% in 2022 and later soared 176208.61% in 2023.
  • Noble Romans' EBIT stood at -$106.0 in 2021, then plummeted by 272.64% to -$395.0 in 2022, then soared by 176208.61% to $695629.0 in 2023, then crashed by 90.18% to $68282.0 in 2024, then soared by 1099.53% to $819065.0 in 2025.
  • The last three reported values for EBIT were $819065.0 (Q3 2025), $913999.0 (Q2 2025), and $501639.0 (Q1 2025) per Business Quant data.